In conclusion, patients with acromegaly have a high prevalence of dyslipidemia, driven by excess GH, insulin resistance, and alterations in lipid metabolism, which collectively increase the risk of atherosclerotic cardiovascular disease. Here, GH1 is linked to acromegaly.